[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336500-105":59,"doc-detail-336500-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","applications-of-modified-mesenchymal-stem-cells-as-targeted-systems-against-tumor-cells","Applications of Modified Mesenchymal Stem Cells as Targeted Systems against Tumor Cells","","Combined gene and cell therapy offers promising strategies for cancer treatment. This review addresses how mesenchymal stem cells (MSCs) can act as a targeted delivery system in solid tumors through dual immune-regulatory and antitumor/protumor effects on the tumor microenvironment. Genetic engineering enables MSCs to overexpress therapeutic genes and more selectively eliminate tumor cells, while effectiveness remains limited by factors including cell source, transgene, and tumor targeting. The work summarizes engineering methods, goals across major cancers, and key challenges, risks, limitations, and advantages of engineered MSCs versus conventional approaches.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/applications-of-modified-mesenchymal-stem-cells-as-targeted-systems-against-tumor-cells/336500/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/applications-of-modified-mesenchymal-stem-cells-as-targeted-systems-against-tumor-cells/336500.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are modified mesenchymal stem cells considered promising for cancer therapy?","Question",{"text":112,"@type":113},"MSC-based strategies can deliver therapeutic genes to tumors and influence the tumor microenvironment via immune/regulatory effects. They can be engineered to overexpress genes for more selective tumor cell elimination.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What factors limit the effectiveness of engineered MSCs in solid tumors?",{"text":117,"@type":113},"The review notes that outcomes depend on factors such as the cell source, the transgene used, and the tumor target. These variables affect how well therapy performs.",{"name":119,"@type":110,"acceptedAnswer":120},"What types of genetic modifications are discussed for MSC-directed therapy?",{"text":121,"@type":113},"The text mentions introducing therapeutic genes into MSCs, including suicide genes, tumor-suppressor and proapoptotic genes, immune-activation genes, and gene-encoding cytokines, to inhibit growth, activate immunity, and induce apoptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336500,1790154478,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Review  \nApplications of Modified Mesenchymal Stem Cells as Targeted Systems against Tumor Cells  \nElsa N. Garza Treviño 1, Adriana G. Quiroz Reyes 1, Paulina Delgado Gonzalez 1, Juan Antonio Rojas Murillo 1, Jose Francisco Islas 1, Santiago Saavedra Alonso 2 and Carlos A. Gonzalez Villarreal 2, *  \nCitation: Garza Treviño, E.N.; Quiroz Reyes, A.G.; Delgado Gonzalez, P.; Rojas Murillo, J.A.; Islas, J.F.; Alonso, S.S.; Gonzalez Villarreal, C.A. Applications of Modified Mesenchymal Stem Cells as Targeted Systems against Tumor Cells. Int. J. Mol. Sci. 2024, 25, 7791. [https://](https://)[ ](https://)[doi.org/10.3390/ijms25147791](doi.org/10.3390/ijms25147791)  \nAcademic Editor: Pritam Sadhukhan  \nReceived: 30 May 2024  \nRevised: 22 June 2024  \nAccepted: 26 June 2024  \nPublished: 16 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Laboratorio de Terapia Celular, Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León, Av. Dr. José Eleuterio González 235, Monterrey 64460, Nuevo León, Mexico; [elsa.garzatr@uanl.edu.mx](elsa.garzatr@uanl.edu.mx) (E.N.G.T.); [guadalupe.quirozrys@uanl.edu.mx](guadalupe.quirozrys@uanl.edu.mx) (A.G.Q.R.); [paulina.delgadogn@uanl.edu.mx](paulina.delgadogn@uanl.edu.mx) (P.D.G.); [juan.rojasmrll@uanl.edu.mx](juan.rojasmrll@uanl.edu.mx) (J.A.R.M.); [jislas.me0117@uanl.edu.mx](jislas.me0117@uanl.edu.mx) (J.F.I.)  \n2 Departamento de Ciencias Básicas, Vicerrectoría de Ciencias de la Salud, Universidad de Monterrey, Ignacio Morones Prieto 4500, Jesus M. Garza, San Pedro Garza García 66238, Nuevo León, Mexico; [santiago.saavendra@udem.edu](santiago.saavendra@udem.edu)  \n* Correspondence: [carlosalberto.gonzalezv@udem.edu](carlosalberto.gonzalezv@udem.edu)  \nAbstract: Combined gene and cell therapy are promising strategies for cancer treatment. Given the complexity of cancer, several approaches are actively studied to fight this disease. Using mesenchymal stem cells (MSCs) has demonstrated dual antitumor and protumor effects as they exert massive immune/regulatory effects on the tissue microenvironment. MSCs have been widely investigated to exploit their antitumor target delivery system. They can be genetically modified to overexpress genes and selectively or more efficiently eliminate tumor cells. Current approaches tend to produce more effective and safer therapies using MSCs or derivatives; however, the effect achieved by engineered MSCs in solid tumors is still limited and depends on several factors such as the cell source, transgene, and tumor target. This review describes the progress of gene and cell therapy focused on MSCs as a cornerstone against solid tumors, addressing the different MSC-engineering methods that have been approached over decades of research. Furthermore, we summarize the main objectives of engineered MSCs against the most common cancers and discuss the challenges, limitations, risks, and advantages of targeted treatments combined with conventional ones.  \nKeywords: cancer; mesenchymal stem cell; cell therapy; exosomes  \n1. Introduction  \nMesenchymal stem cells (MSCs) are a type of multipotent cell found in various body tissues [1], including bone marrow [2], adipose tissue [3], the umbilical cord [4] and other connective tissues. In addition to their ability to differentiate into a range of cell types, such as osteoblasts, chondrocytes, adipocytes, and muscle cells [1], MSCs also exhibit immunomodulatory and anti-inflammatory properties that make them extremely valuable for research and clinical application in regenerative therapies and the treatment of various diseases [5] . MSCs have been studied in vitro and in vivo ","cbCaikeGiK9xXGFI","https://ap.wps.com/l/cbCaikeGiK9xXGFI","pdf",1344444,"English","# Introduction\n## Mesenchymal stem cells as multipotent, immunomodulatory vehicles\n## MSC gene engineering and tumor-homing rationale\n## Therapeutic targets for directing MSCs in solid tumors","[{\"question\":\"Why are modified mesenchymal stem cells considered promising for cancer therapy?\",\"answer\":\"MSC-based strategies can deliver therapeutic genes to tumors and influence the tumor microenvironment via immune/regulatory effects. They can be engineered to overexpress genes for more selective tumor cell elimination.\"},{\"question\":\"What factors limit the effectiveness of engineered MSCs in solid tumors?\",\"answer\":\"The review notes that outcomes depend on factors such as the cell source, the transgene used, and the tumor target. These variables affect how well therapy performs.\"},{\"question\":\"What types of genetic modifications are discussed for MSC-directed therapy?\",\"answer\":\"The text mentions introducing therapeutic genes into MSCs, including suicide genes, tumor-suppressor and proapoptotic genes, immune-activation genes, and gene-encoding cytokines, to inhibit growth, activate immunity, and induce apoptosis.\"}]","Applications of Modified Mesenchymal Stem Cells as Targeted Systems against Tumor Cells | PDF",1790015359,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee00dd67b217e7b1d1b8d04c61f4b4b4.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4ebe9d26c9867607e26e169e60ce285.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1299dc62092b2056cf19f3300ed438a3.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38b8bd6968a680ceb158b954871ff430.webp",980,1385]